WELCOME

Mechanism of Bacteriophage-Bacteria Interaction

Evolutionary Arms Race: Bacteria develop defense systems (CRISPR-Cas, restriction-modification, abortive infection, surface receptor mutation). Phages co-evolve counter-defenses (anti-CRISPR proteins, receptor binding mutations, overcoming restriction).

Dependency: Phages rely entirely on host energy, ribosomes, nucleotides, and amino acids for replication.

Complexity:Specific mechanisms vary significantly between phage families and bacterial hosts (Gram-positive vs. Gram-negative, structure differences).

Phage Therapy for Drug-Resistant Bacteria

Phage therapy leverages bacteria-killing viruses (bacteriophages) to combat multidrug-resistant (MDR) bacterial infections where antibiotics fail. These highly specific phages infect target bacteria, replicate within them, and lyse host cells, releasing new phage particles to amplify treatment locally. Clinical successes include curing life-threatening infections like those caused by MDR Pseudomonas aeruginosa and Acinetobacter baumannii, particularly in compassionate-use cases. Engineered phage cocktails and CRISPR-enhanced phages broaden efficacy against evolving resistance, while phage-derived enzybiotics (e.g., lysins) offer direct peptidoglycan degradation. Synergy with antibiotics enhances bacterial eradication and reduces resistance emergence. Despite regulatory and standardization challenges, phage therapy represents a promising, evolution-informed precision antimicrobial strategy against the global antibiotic resistance crisis.

Phage-Derived Antimicrobial Protein

As resistance genes outpace antibiotic development, these precision protein therapeutics—tunable, evolution-informed, and minimally disruptive to microbiomes—represent a transformative frontier in anti-infective strategy. Ongoing advances in synthetic biology and delivery systems position phage-derived AMPs as cornerstone solutions for the post-antibiotic era. These peptidoglycan hydrolases, once released by phages to lyse host cells, have been repurposed as "enzybiotics." Capsule/glycan-degrading enzymes disrupt biofilms and sensitize bacteria to antibiotics. Engineered pore-forming holins and membrane-disrupting spanins show promise as precision "molecular scissors," particularly against Gram-negative ESKAPE pathogens.

Gut Microbiome

Research on the gut microbiome has revolutionized our understanding of its complex ecosystem, revealing profound implications for human health beyond digestion. This intricate community encompasses bacteria, archaea, fungi, eukaryotes, and crucially, the ​gut virome, dominated by ​bacteriophages (phages)​. Modern metagenomic sequencing allows deep characterization, showing that gut phages dynamically shape bacterial populations through predation, driving diversity and stability via "kill-the-winner" dynamics, while also facilitating horizontal gene transfer, including antibiotic resistance and virulence factors.